Reported 3 days ago
Qiagen has entered a partnership with French company ID Solutions to enhance the availability of digital PCR assays aimed at oncology research. This collaboration leverages Qiagen's global reach and automation with ID Solutions' assay development, focusing on creating assays for non-clinical research use on Qiagen's QIAcuity platforms. The new assays will enable simultaneous detection of multiple mutations in cell-free DNA from plasma and genomic DNA from formalin-fixed tissues, initially marketed in Europe with plans for expansion, promising results in under a day.
Source: YAHOO